Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Neuroblastoma × 30 days × Clear all

Status

Sponsor Class

Study Type

Interventional 43 Observational 5 Expanded_access 1

Sponsor

Cancer Type

Conditions

Non-Muscle Invasive Bladder Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Osteosarcoma 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neuroblastoma 1 Neoplasms 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Desmoid Tumors 1 Carcinoma, Transitional Cell 1

Interventions

3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01163383 2026-04-13

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

Children's Hospital of Philadelphia

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡